Medi-Caps Limited
BSE: MEDICAPQ
Prev Close
39.88
Open Price
39.62
Volume
1,280
Today Low / High
39.62 / 40.94
52 WK Low / High
37.23 / 61
Range
38 - 42
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 39.88, reflecting a change of 0 (0%). The expected target range on the BSE is 38 - 42. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Medi-Caps Limited Graph
Medi-Caps Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Medi-Caps Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 39.88, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 39.88 | 40.28 | 36.25 - 44.31 |
| 40.68 | 32.54 - 48.81 | ||
| 41.08 | 28.75 - 53.40 | ||
| Bearish Scenario | 39.88 | 39.48 | 35.53 - 43.43 |
| 39.08 | 31.27 - 46.90 | ||
| 38.68 | 27.08 - 50.29 |
Overview of Medi-Caps Limited
ISIN
INE442D01010
Industry
Medical - Pharmaceuticals
Vol.Avg
4,336
Market Cap
497,303,600
Last Dividend
0
Official Website
IPO Date
2002-03-20
DCF Diff
3.61
DCF
37
Financial Ratios Every Investor Needs
Stock Dividend of MEDICAPQ
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2012-09-20 | September 20, 12 | 0.375 | 1.5 | |||
| 2011-09-22 | September 22, 11 | 0.375 | 1.5 | |||
| 2010-09-22 | September 22, 10 | 0.375 | 1.5 | |||
| 2009-09-24 | September 24, 09 | 0.375 | 1.5 | |||
| 2008-09-24 | September 24, 08 | 0.375 | 1.5 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 25.37 Cr | 10.65 Cr | 14.72 Cr | 0.5802 | 0.00 Cr | 7.58 Cr | -3.55 Cr | -0.57 Cr | -0.46 | 0.90 Cr | -0.0225 |
| 2024-03-31 | 26.56 Cr | 18.82 Cr | 7.74 Cr | 0.2915 | 0.03 Cr | 2.27 Cr | -1.72 Cr | -2.24 Cr | -1.80 | 0.48 Cr | -0.0844 |
| 2023-03-31 | 48.58 Cr | 25.11 Cr | 23.47 Cr | 0.4831 | 0.03 Cr | 0.48 Cr | 2.82 Cr | 1.76 Cr | 1.41 | 6.79 Cr | 0.0361 |
| 2022-03-31 | 68.31 Cr | 33.45 Cr | 34.86 Cr | 0.5103 | 0.03 Cr | 0.35 Cr | 8.25 Cr | 10.08 Cr | 8.08 | 11.97 Cr | 0.1476 |
| 2021-03-31 | 57.42 Cr | 32.08 Cr | 25.34 Cr | 0.4413 | 0.03 Cr | 0.45 Cr | 10.45 Cr | 11.13 Cr | 8.92 | 12.86 Cr | 0.1938 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.41 Cr | 125.42 Cr | 4.15 Cr | 121.2766 Cr | 0.00 Cr | -0.41 Cr | 3.20 Cr | 28.03 Cr | 0.00 Cr | 0.00 Cr | 15.42 Cr | 3.0987 Cr |
| 2024-03-31 | 0.32 Cr | 127.28 Cr | 6.30 Cr | 120.9832 Cr | 0.00 Cr | -0.32 Cr | 5.74 Cr | 29.43 Cr | 1.57 Cr | 0.00 Cr | 9.32 Cr | 5.2596 Cr |
| 2023-03-31 | 1.11 Cr | 125.99 Cr | 7.42 Cr | 118.5712 Cr | 0.00 Cr | -1.11 Cr | 7.07 Cr | 30.77 Cr | 1.32 Cr | 0.00 Cr | 6.49 Cr | 5.1666 Cr |
| 2022-03-31 | 0.23 Cr | 130.35 Cr | 14.09 Cr | 116.2560 Cr | 0.00 Cr | -0.23 Cr | 11.85 Cr | 31.42 Cr | 0.48 Cr | 0.00 Cr | 3.72 Cr | 13.1998 Cr |
| 2021-03-31 | 0.39 Cr | 114.82 Cr | 10.11 Cr | 104.7124 Cr | 0.00 Cr | -0.39 Cr | 6.71 Cr | 30.52 Cr | 0.00 Cr | 0.00 Cr | -30.67 Cr | 9.2704 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 5.0688 Cr | -4.9782 Cr | 0.0000 Cr | 4.7429 Cr | 0.0906 Cr | 0.4120 Cr | -0.3259 Cr | -0.8411 Cr | 0.0000 Cr | 0.0000 Cr | 2.5356 Cr |
| 2024-03-31 | 6.9430 Cr | -7.7351 Cr | 0.0000 Cr | 6.5972 Cr | -0.7922 Cr | 0.3214 Cr | -0.3458 Cr | -2.2408 Cr | 0.0000 Cr | 0.0000 Cr | 1.3331 Cr |
| 2023-03-31 | -6.0810 Cr | -2.5602 Cr | 0.0000 Cr | -7.2438 Cr | -8.6413 Cr | 1.1135 Cr | -1.1628 Cr | 4.9209 Cr | 0.0000 Cr | 0.0000 Cr | 4.7808 Cr |
| 2022-03-31 | 7.0210 Cr | -4.0751 Cr | 0.0000 Cr | 4.2275 Cr | 2.9459 Cr | 9.7549 Cr | -2.7935 Cr | 10.0577 Cr | 0.0000 Cr | 0.0000 Cr | -5.1437 Cr |
| 2021-03-31 | 15.3188 Cr | -9.6992 Cr | -0.0635 Cr | 13.0620 Cr | 5.5562 Cr | 6.8090 Cr | -2.2568 Cr | 11.2450 Cr | -0.0635 Cr | 0.0000 Cr | -1.2598 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 6.94 Cr | 2.78 Cr | 4.16 Cr | 0.5997 | -0.67 Cr | 1.72 Cr | 1.38 | 1.91 Cr | 0.2478 |
| 2024-12-31 | 4.01 Cr | 1.88 Cr | 2.13 Cr | 0.5307 | -2.20 Cr | -2.05 Cr | -1.64 | -1.62 Cr | -0.5101 |
| 2024-09-30 | 8.28 Cr | 3.93 Cr | 4.35 Cr | 0.5254 | 0.03 Cr | 0.31 Cr | 0.25 | 0.74 Cr | 0.0377 |
| 2024-06-30 | 6.19 Cr | 4.64 Cr | 1.56 Cr | 0.2514 | -0.70 Cr | -0.56 Cr | -0.45 | -0.13 Cr | -0.0898 |
| 2024-03-31 | 7.87 Cr | 5.51 Cr | 2.36 Cr | 0.3001 | -0.83 Cr | -1.08 Cr | -0.86 | -0.26 Cr | -0.1370 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.41 Cr | 28.70 Cr | 29.11 Cr | 8.79 Cr | 3.20 Cr | 53.44 Cr | 28.03 Cr | 125.42 Cr | 4.15 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 33.58 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -123.73 Cr |
| 2024-09-30 | 0.98 Cr | 32.60 Cr | 33.58 Cr | 8.17 Cr | 4.98 Cr | 60.09 Cr | 28.61 Cr | 128.92 Cr | 5.19 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 30.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -120.98 Cr |
| 2024-03-31 | 0.32 Cr | 35.31 Cr | 35.63 Cr | 16.09 Cr | 5.74 Cr | 60.01 Cr | 29.43 Cr | 127.28 Cr | 6.30 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | -2.05 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -0.56 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -1.08 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2013-03-19 | March 19, 13 | 4:1 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹804.05 | ₹96,279,696,851.00 | ₹756,659.00 |
Key Executives
Gender: male
Year Born: 1969
Gender: male
Year Born:
Gender: male
Year Born: 1991
FAQs about Medi-Caps Limited
The CEO is Alok K. Garg.
The current price is ₹39.88.
The range is ₹37.23-61.
The market capitalization is ₹49.73 crores.
The P/E ratio is -87.09.
The company operates in the Healthcare sector.
Overview of Medi-Caps Limited (ISIN: INE442D01010) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹49.73 crores and an average daily volume of 4,336 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.